Symbols / AIH
AIH Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | — | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | — |
| Price | — | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
No analyst ratings or price targets available.
News
RSS: Latest AIH news- Advanced Innergy marks post-IPO growth surge with strong FY25 and segment expansion - The Globe and Mail Sat, 21 Feb 2026 00
- Advanced Innergy Adopts Amended Constitution After Shareholder Approval - TipRanks ue, 24 Feb 2026 05
- Advanced Innergy Wins Full Shareholder Backing at 2025 AGM - TipRanks Fri, 20 Feb 2026 01
- Kezar Life Sciences to lay off 70% of workforce as dispute with FDA apparently continues - The Business Journals Mon, 10 Nov 2025 08
- Kezar Launches Review After FDA Blocks Liver Drug Plans - Kezar Life Sciences (NASDAQ:KZR) - Benzinga Fri, 17 Oct 2025 07
- Kezar Life Sciences Reports First Quarter 2025 Financial Results and Provides Business Update - Business Wire ue, 13 May 2025 07
- Advanced Innergy begins ASX trading after $150m IPO; reiterates FY26 guidance - Proactive financial news Fri, 31 Oct 2025 07
- Breakthrough in Autoimmune Hepatitis: Kezar's Drug Achieves 36% Response Rate While Placebo Shows Zero - Stock Titan ue, 25 Mar 2025 07
- Marimaca Copper Announces Proposed US$17.7 Million Non-Brokered Private Placement - GlobeNewswire Wed, 04 Jun 2025 07
- Undiscovered Gems in Australia to Explore February 2026 - simplywall.st Wed, 04 Feb 2026 08
- ASX IPOs: Advanced Innergy's $400 million debut tests industrial appetite - Market Index Fri, 31 Oct 2025 07
- Kezar mulls strategic options after clash with FDA on zetomipzomib's autoimmune hepatitis programme - FirstWord Pharma hu, 16 Oct 2025 07
- Japfa's AustAsia to launch IPO on Dec 15 - Yahoo Finance Singapore Wed, 14 Dec 2022 08
- The Rise of Autoimmune Hepatitis Worldwide: A Closer Look - Managed Healthcare Executive hu, 02 Nov 2023 07
- AIH Purchases Sam’s Club Warehouse in South Anchorage - Alaska Business Magazine hu, 17 Dec 2020 08
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for AIH
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|